Study Evaluating the Impact of Electronic Surveys on Patient-physician Communication and Quality of Life in Breast Cancer Patients
Breast Neoplasm Malignant Female
About this trial
This is an interventional health services research trial for Breast Neoplasm Malignant Female
Eligibility Criteria
Inclusion Criteria:
- Stage IV breast cancer
- Start of a systemic anti cancer therapy: chemotherapy -/+ antibody therapy 1st until 3rd line (palliative), endocrine therapy or other therapy without limit
- Estimated life expectancy of minimum six months
- Signed informed consent
- No cognitive or speech impairments
Sites / Locations
- A.ö. Krankenhaus St. Josef Braunau GmbH
- Klinikum Wels-Grieskirchen GmbH
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Intervention Arm
Control Arm
Quality of life questionnaires (electronic patient reported outcomes) to be filled out by the patients at every visit. Quality of life data is fully available for physicians. Paper-based questionnaire (EORTC QLQ-COMU26) at baseline, after three months and after six months.
Quality of life questionnaires (electronic patient reported outcomes) only to filled out by the patients at baseline, after three months and after six months. Quality of life data is hidden for physicians. Paper-based questionnaire (EORTC QLQ-COMU26) at baseline, after three months and after six months.